Fact CheckerSign in

NCT05439876CompletedPhase 2/3

Getting SMART for Pediatric Epilepsy

Getting SMART for Pediatric Epilepsy (Sleep, Melatonin, and Research Trial, SMART)

Source: ClinicalTrials.gov · Last updated 9 Oct 2026

Brief summary (registry, in English)

The purpose of this study is to evaluate the effect of melatonin for improving sleep in pediatric epilepsy.

Status (registry)
Completed
Phase (registry)
Phase 2/3
Study type
Interventional
Enrollment
147 (actual)
First submitted
20 Jun 2022
Start date
18 Jul 2022
Primary completion date
3 Jan 2025
Lead sponsor
National Taiwan University Hospital
Diseases
Epilepsy
NCT number
NCT05439876

What you commit to

  • Study type: Interventional · Phase 2/3
  • Participants enrolled: 147
  • From 18 Jul 2022 to the primary completion date, 3 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Children on hypnotics, antidepressants, or anxiolytics within 4 weeks before the baseline clinic visit

Other

  • Children who are bedridden with limited mobility
  • Children with liver or kidney dysfunction
  • Adolescent girls who are pregnant or breastfeeding
  • Adolescent girls who have sexual activities but cannot take effective contraceptive measures during the trial

Who the study is looking for

  • \- Children aged between 1 and 18 years with a confirmed diagnosis of epilepsy and with sleep problems

Age in the registry: 1 year to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Taiwan University Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.